These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 9329623)
1. The endothelial marker CD 34 in the assessment of tumour vascularisation in ovarian cancer. Heimburg S; Oehler MK; Kristen P; Papadopoulos T; Caffier H Anticancer Res; 1997; 17(4B):3149-51. PubMed ID: 9329623 [TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer. Heimburg S; Oehler MK; Papadopoulos T; Caffier H; Kristen P; Dietl J Anticancer Res; 1999; 19(4A):2527-9. PubMed ID: 10470188 [TBL] [Abstract][Full Text] [Related]
3. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566 [TBL] [Abstract][Full Text] [Related]
4. Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer. Suhonen KA; Anttila MA; Sillanpää SM; Hämäläinen KM; Saarikoski SV; Juhola M; Kosma VM Eur J Cancer; 2007 May; 43(8):1300-7. PubMed ID: 17448653 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Lincoln DT; Singal PK; Al-Banaw A Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592 [TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment serum hemoglobin level and a preliminary investigation of intratumoral microvessel density in advanced ovarian cancer. Ferrero A; Zola P; Mazzola S; Fuso L; Sarotto I; Ravarino N; Spanu PG; Jacomuzzi ME; Carus AP; Sismondi P Gynecol Oncol; 2004 Nov; 95(2):323-9. PubMed ID: 15491752 [TBL] [Abstract][Full Text] [Related]
8. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246 [TBL] [Abstract][Full Text] [Related]
9. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia. Smolej L; Kasparová P APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of tumour angiogenesis in adenocarcinoma and squamous cell carcinoma of lung. Sikora J; Słodkowska J; Radomyski A; Giedronowicz D; Kobos J; Kupis W; Rudzinski P Rocz Akad Med Bialymst; 1997; 42 Suppl 1():271-9. PubMed ID: 9337544 [TBL] [Abstract][Full Text] [Related]
11. Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression. Rmali KA; Watkins G; Harrison G; Parr C; Puntis MC; Jiang WG Eur J Surg Oncol; 2004 Nov; 30(9):948-53. PubMed ID: 15498639 [TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival. Ali-Fehmi R; Morris RT; Bandyopadhyay S; Che M; Schimp V; Malone JM; Munkarah AR Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677 [TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Hoskin PJ; Sibtain A; Daley FM; Saunders MI; Wilson GD Radiother Oncol; 2004 Aug; 72(2):159-68. PubMed ID: 15297134 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Hansen S; Grabau DA; Rose C; Bak M; Sørensen FB Lab Invest; 1998 Dec; 78(12):1563-73. PubMed ID: 9881956 [TBL] [Abstract][Full Text] [Related]
15. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas. Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099 [TBL] [Abstract][Full Text] [Related]
16. An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model. van der Laak JA; Westphal JR; Schalkwijk LJ; Pahlplatz MM; Ruiter DJ; de Waal RM; de Wilde PC J Pathol; 1998 Feb; 184(2):136-43. PubMed ID: 9602703 [TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours. Hall GH; Turnbull LW; Bedford K; Richmond I; Helboe L; Atkin SL Int J Oncol; 2005 Nov; 27(5):1283-8. PubMed ID: 16211223 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary. Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489 [TBL] [Abstract][Full Text] [Related]
19. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation. Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336 [TBL] [Abstract][Full Text] [Related]
20. Assessment of angiogenesis in soft-tissue tumors. Baneth V; Raica M; Cîmpean AM Rom J Morphol Embryol; 2005; 46(4):323-7. PubMed ID: 16688371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]